Oxford Biomedica, Carnegie Institute, University of Massachusetts Medical School, University of Houston, Eureka Genomics, BioTime, Wisconsin Alumni Research Foundation, Yissum, Eucalyptus, Tempo Pharmaceuticals, BrainStorm Cell Therapeutics, Rutgers Unive | GenomeWeb
Oxford Biomedica Licenses RNAi Tech from Carnegie Institute, UMMS
Gene therapy company Oxford Biomedica said this week that it has licensed the rights for RNA interference technology from the University of Massachusetts Medical School and the Carnegie Institute of Washington.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.